CDSCO Publishes Drug Alert List for March 2024

The CDSCO has stated that in the month of March 2024 it received 612 samples and tested 931 samples. Among these samples, it observed that 66 samples did not possess standard quality and identified 1 sample as misbranded.

DCGI Cancels Stakeholder Meeting Scheduled on April 16th

The Central Drugs Standard Control Organization (CDSCO) has announced the cancellation of the upcoming Drug Controller General of India (DCGI) stakeholder meeting scheduled for April 16th, 2024. CDSCO has encouraged stakeholders to contact the Nodal Officer of the PRO Cell to schedule individual meetings on alternative dates.

Government Emphasizes Awareness and Collaboration For Management of Heatwaves

The Ministry informed that advisories emphasizing state compliance with the National Action Plan on Heat Related Illnesses were recently issued to Chief Secretaries. These plans detail essential medicine stockpiling, intravenous fluids, ice packs, ORS solutions, and public awareness campaigns. Additionally, the National Centre for Disease Control (NCDC) has prepared a guide on recommended practices for both the general public and vulnerable individuals during summer months.

Strengthening Private Medical Device Testing Facilities in India

CDSCO has issued a public notice issued inviting applications from existing private labs to register for testing specific medical devices. These tests include physical, chemical, microbiological, mechanical, and electrical examinations. Interested private labs can submit applications in Form MD-39, along with the requisite fees.